503b glp-1 FDA Enforcement FDA crackdown halts GLP-1 production

Today we announced positive topline results from the first Phase 1b clinical trial of elecoglipron conducted in China in adults living with obesity/overweight, with or without type 2 diabetes

Convenient single-serve options

Medullary thyroid cancer is rare

Please check the ingredient list on the product packaging for the most up-to-date information and to ensure it is suitable for your personal use

Learn about effective dosages, FDA safety guidelines, individual response factors, and how allulose compares to pharmaceutical GLP-1 medications for blood sugar control.

Companies are investing in research and development